投稿者名:tagoaika

Respect Without Romanticizing: Cultural Values, Parental Reasons, and Unproven Pediatric Treatments in East Asia Hiroshima University ethicists argue that absolute genetic confidentiality can harm families and the public Bioethics researchers from Japan and Korea have jointly published a critical examination of how to evaluate and respect “parental reasons” when making decisions about whether to undergo unproven pediatric treatments to children. The study, which published in The American Journal of Bioethics, analyzes two prominent cases in East Asia: South Korea’s Hwang Woo-suk stem cell scandal and Japan’s umbilical cord blood controversy, and show how sincere parental devotion can be manipulated by researchers, clinicians, and commercial entities when scientific uncertainties are obscured by moral rhetoric. ”Our goal is to respect cultural values without making them unconditionally paramount,” said Tsutomu Sawai, a Hiroshima University professor (special recognition) and autho

Ethics should lead, not play catch-up, Hiroshima University expert emphasizes as Japan panel OKs making human embryos from stem cells As Japan moves closer to becoming the first nation to allow research on human embryos created from lab-grown sperm and eggs, a leading bioethicist at Hiroshima University has cautioned against the widening gap between rapid scientific advances and slower pace of ethical and societal deliberation. A leading bioethicist at Hiroshima University is calling for an anticipatory, rather than reactive, approach to ethics after a Japanese government panel in August backed a report that brings the country a step closer to becoming the first in the world to allow research on human embryos created from stem cell–derived sperm and eggs. In a correspondence article titled “Ethics must keep pace with embryo research” published in the journal Nature (Vol. 646), Hiroshima University Professor (Special Recognition) Tsutomu Sawai cautions that science is advancing faster

Patient privacy is not always paramount Hiroshima University ethicists argue that absolute genetic confidentiality can harm families and the public A new study from Hiroshima University challenges the long-held belief that patient confidentiality should always take precedence in medicine. In their essay, published in The American Journal of Bioethics, Rie Iizuka, Shu Ishida, and Tsutomu Sawai critically assess philosopher M. K. Kilbride’s suggested framework for determining when healthcare professionals may disclose a patient’s genetic information without consent.   The authors argue that when it comes to genetic information, refusing to disclose risks to family members can perpetuate harm across generations, particularly for hereditary conditions such as cancer that often emerge only after individuals have children.   The Hiroshima team argues that Kilbride’s model, which requires six strict conditions all be met before disclosure, is too restrictive and the conditions can contradict

Japanese scholars submit a nuanced view linking diverse disability experiences Researchers at Hiroshima University (Japan) have introduced a new philosophical framework—“conditional bad-difference view” (Conditional BDV)—to understanding ethically important featuresof disability. Published in the journal Bioethics , Conditional BDV offers a nuanced way to think about the relationship between disability and well-being, aiming to better reflect and respect the diverse experiences of disabled individuals. The Conditional BDV was developed in response to shortcomings in the two dominant philosophical perspectives for disabilities. The “bad-difference view” (BDV) holds that a disability is inherently detrimental to well-being, even in ideal situations without discrimination against disabled people. By  contrast, the “mere-difference view” (MDV) considers a disability as ethically neutral in such nondiscriminatorysettings, just like race and gender. The novel Conditional BDV challenges this